sarcoidosis%20-%20pulmonary
SARCOIDOSIS - PULMONARY
Sarcoidosis is a multisystem disease which may present with non-specific symptoms or symptoms related to organ-specific involvement.
Non-specific symptoms include fever, malaise, fatigue and weight loss.
Pulmonary involvement is seen in >90% of sarcoidosis patients.

Diagnosis

  • Diagnosis is often delayed because of the usual non-specific presentation

Diagnosis is based on the following:

  • Compatible clinical or radiologic picture or both
  • Histologic proof of non-caseating granuloma
  • Exclusion of similar diseases

Staging

Staging of Pulmonary Sarcoidosis based on Chest X-ray (CXR)

Stage 0

  • Normal CXR

Stage 1

  • Lymphadenopathy
    • Hilar & paratracheal nodes are usually involved
    • Parenchymal granulomas may be found on biopsy even in the absence of infiltrates on CXR

Stage 2

  • Lymphadenopathy w/ parenchymal infiltrates

Stage 3

  • Parenchymal infiltration w/o lymphadenopathy
  • Progressive loss of lung function may occur

Stage 4

  • Advanced fibrosis
  • Other findings include emphysema, bullae, cysts, hilar retraction & honey-combing
  • Progressive loss of lung function may occur

History

  • A thorough clinical history & physical exam should be obtained
  • Though the cause of sarcoidosis is unknown, the patient should be questioned carefully about exposure to both inorganic & organic antigens
  • Investigate possible environmental & occupational exposures that may reveal an alternative diagnosis
    • Exposure to metal dusts, fumes & organic antigens may cause granulomatous diseases that are difficult to differentiate from sarcoidosis

Extrapulmonary Disease

  • Physical exam should include a search for evidence of extrapulmonary disease
    • Evidence of multi-organ involvement is supportive of a diagnosis of sarcoidosis

Laboratory Tests

Biopsy & Histology

  • Transbronchial lung biopsy to demonstrate granulomas is recommended in most cases
    • Has a higher yield for patients w/ parenchymal lung disease seen on CXR or CT scan
  • Accessible skin lesions &/or lymph nodes may also be biopsied
  • Surgical biopsy is indicated when transbronchial or bronchial biopsies are not diagnostic & no other accessible biopsy sites are identified

Other Diagnostic Procedures/Laboratory Exams

Bronchoalveolar Lavage (BAL)

  • Increased lymphocytes are seen or an increased CD4:CD8 ratio
  • Findings are supportive, but not definitive of a diagnosis

Angiotensin Converting Enzyme (ACE) Levels

  • Elevations are not diagnostic since other diseases & granulomatous conditions may present w/ high levels of ACE
  • Additional evaluation is recommended in all patients diagnosed w/ sarcoidosis

Laboratory Exams

  • Pulmonary function tests
    • Spirometry
    • Diffusing capacity for carbon monoxide (DLco)
  • Peripheral blood counts
  • Serum chemistries
    • Blood urea nitrogen (BUN), creatinine, calcium
    • Liver enzymes: Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) 
  • Urinalysis
    • Patients may present w/ hypercalciuria
  • Electrocardiogram (ECG)
    • Patients may manifest w/ cardiac arrhythmias
  • Routine ophthalmologic evaluation
    • To determine if eye involvement is present
  • Tuberculin test

Imaging

Chest X-ray (CXR)

  • Presence of bilateral hilar enlargement may speed up the diagnostic process
  • Interstitial disease alone may be seen

Computed Tomography (CT) scan

  • May be used to identify patients w/ parenchymal disease not seen on CXR
  • Demonstrates hilar & mediastinal lymphadenopathy
  • May also be done when patients present w/ atypical clinical or radiologic findings
  • Allows detection of complications of the disease (eg bronchiectasis, aspergilloma, pulmonary fibrosis)
  • Consider CT when there is clinical suspicion of the disease but the CXR is normal

Total Body Gallium Scan

  • Appearance of a Panda pattern combined w/ a Lambda pattern may support diagnosis
  • Findings are present only in a small number of patients
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Stephen Padilla, 09 Jan 2018
Very elderly adults have the highest rate of invasive pneumococcal diseases, according to a recent study, suggesting that age influences manifestations of this illness.
27 Dec 2017
The prevalence of allergic diseases in the Asia-Pacific region is expected to rise over the next 20 years, driven by rapid economic development and urbanization. Allergic diseases have high socioeconomic impact by impairing productivity and quality of life, and the impact may be greater in Asia-Pacific than in Europe due to the presence and predominance of perennial allergens.
23 Oct 2014
This study validated the effect of subglottic secretion suctioning on ventilator-associated pneumonia prevalence and to gauge its associated impact on ventilator-associated conditions and antibiotic use.